Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2024 - Mental Daily. All Rights Reserved.
Clinical

New research claims COVID-19 contagion may raise the risk of neurodegenerative disorder

Staff Writer
Staff Writer 3 years ago
Updated 2022/05/19 at 2:37 AM
Share
SHARE

A new study examining rodent subjects suggest that Parkinson’s disease may develop amid COVID-19 contagion.

The research was publicized in the journal Movement Disorders.

In the study, although COVID-19 did not directly affect dopaminergic neurons in the basal ganglia, low dose of MPTP after recovering from contagion resulted in Parkinson’s disease neuronal changes.

“K18-hACE2 mice were infected with SARS-CoV-2 to induce mild to moderate disease,” according to the study. “After 38 days recovery, mice were administered a non-lesion inducing dose of the parkinsonian toxin MPTP and euthanized 7 days later. Subsequent neuroinflammation and SNpc dopaminergic neuron loss was determined and compared to SARS-CoV-2 or MPTP alone.”

“Our observations have important implications for long-term public health, given the number of people that have survived SARS-CoV-2 infection as well as for future public policy regarding infection mitigation,” the authors determined.

“However, it will be critical to determine if other agents known to increase risk of PD also have synergistic effects with SARS-CoV-2 and are abrogated by vaccination.”

Photo: stock.adobe.com

You Might Also Like

Study explores victim-blaming, manipulation, and denial as tactics used by terrorists

Study finds majority of prisoners receive no visitors, possibly affecting recidivism

Dementia risk factors differ by ethnicity, according to new research

Researchers investigate how endocannabinoids regulate the brain’s stress response

Study shows the risk of eating disorders may be lower among vegans

TAGGED: COVID-19, SARS-CoV-2, parkinson's disease
Staff Writer May 18, 2022
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article ALS experimental drug NU-9 more efficacious than existing FDA-approved drugs
Next Article Study finds diet may be a contributing factor in ADHD symptoms associated in children

Recommended

Clinical

Study explores victim-blaming, manipulation, and denial as tactics used by terrorists

1 Min Read
Clinical

Study finds majority of prisoners receive no visitors, possibly affecting recidivism

2 Min Read
Clinical

Dementia risk factors differ by ethnicity, according to new research

2 Min Read
Clinical

Researchers investigate how endocannabinoids regulate the brain’s stress response

2 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
  • Mental Health
Follow US

© 2024 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?